Microwave ablation (MWA) has emerged as an advanced, minimally invasive treatment for various benign and malignant diseases affecting organs such as the uterus, thyroid, liver, lungs, kidneys, bones, veins, and breast. The technology operates on the principle of electromagnetic energy, where a microwave antenna is guided into the targeted tissue under imaging supervision. Polar molecules within the tumor rapidly vibrate in response to the microwave field, generating heat through molecular friction. When the temperature exceeds 60°C, protein denaturation occurs, leading to irreversible necrosis of tumor cells while sparing surrounding healthy tissues. This technique ensures high precision, minimal complications, faster recovery, and improved patient comfort.
In gynecology, microwave ablation has shown remarkable results in treating uterine fibroids and adenomyosis. It preserves the uterus, avoids surgical scars, and maintains ovarian function and normal menstrual cycles. Symptoms like heavy bleeding, dysmenorrhea, anemia, and pelvic pain are significantly reduced after ablation. MWA can be performed percutaneously or transvaginally, ensuring minimal trauma and short procedural time. Similarly, for thyroid nodules, MWA provides an aesthetic, scar-free solution with minimal complications, making it ideal for younger patients seeking cosmetic preservation.
In the liver and kidney, MWA efficiently destroys small tumors through precise, image-guided energy delivery, offering quick recovery and shorter hospital stays. It also proves effective in lung cancer, osteoid osteoma, and breast fibroadenoma, where it ensures organ preservation and rapid symptom relief. Furthermore, microwave intravascular coagulation is transforming the treatment of varicose veins, providing a pain-free, non-surgical, and highly effective solution.
Overall, microwave ablation represents the future of minimally invasive oncology and benign tumor treatment. It combines high efficacy, safety, and cosmetic benefits, making it a preferred choice for patients and clinicians worldwide.
